Profile
Settings
Refer your friends
Sign out
Why in the News?
Recently, Bharat Biotech’s intranasal Covid vaccine, iNCOVACC gets DCGI nod for restricted emergency use.
Key Points:
About iNCOVACC:
- It is a first covide vaccine which will be delivered through the nasal route.
- Developed by: Bharat Biotech International Limited
- It can be administered only to the unimmunised.
- The vaccine uses a modified chimpanzee adenovirus, which cannot replicate in the body, to carry the Covid spike protein to induce immunity.
- Currently, Covishield, Covaxin and Corbevax are part of the Government’s Covid immunisation drive while vaccines like Covovax and Sputnik are available at private centres.
Significance:
- It protects against infection and reduce transmission of the virus.
- It will do away with the need for needles and syringes.
- Reduce dependence on trained personnel to administer the shots.
- Stable at 2-8°C, which makes it easy to store and distribute.
